Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jennifer Gray

Pediatrics Pearland, TX Medical Doctor

NPI 1790798619 CMS profile 499798

2017 Broadway St, Ste. A, Pearland, TX 77581

Open in the dashboard

General payments

$5,028

276 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jennifer Gray of Pearland, TX is reported in the CMS Open Payments database as having received $5,028 across 276 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $826 49
2024 General $1,151 41
2023 General $642 34
2022 General $831 56
2021 General $582 35
2020 General $326 22
2019 General $669 39

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jennifer Gray
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Jennifer Gray were reported at $826. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Jennifer Gray Pediatrics median Middle half National median
2019 $669 $86 $31–$183 $163
2020 $326 $49 $22–$110 $114
2021 $582 $68 $27–$158 $132
2022 $831 $77 $30–$173 $149
2023 $642 $88 $33–$190 $160
2024 $1,151 $94 $34–$206 $164
2025 $826 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Supernus Pharmaceuticals, Inc. $921 24 payments
  2. Tris Pharma Inc $761 54 payments
  3. Corium, Inc. $457 38 payments
  4. Pfizer Inc. $413 16 payments
  5. Neos Therapeutics, LP $392 29 payments
  6. Merck Sharp & Dohme Corporation $317 21 payments
  7. Cranial Technologies, Inc $298 20 payments
  8. GlaxoSmithKline, LLC. $272 14 payments
  9. Collegium Pharmaceutical, Inc. $161 12 payments
  10. Takeda Pharmaceuticals U.S.A., Inc. $153 8 payments
  11. Other $883 40 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,028 276 payments
Products named General payments · program years 2019–2025
  1. Qelbree $768 16 payments
  2. Azstarys $457 38 payments
  3. COTEMPLA XR-ODT $350 26 payments
  4. Doc Band $298 20 payments
  5. Quillivant $258 18 payments
  6. Quillivant XR $232 18 payments
  7. VYVANSE $229 12 payments
  8. BEXSERO $228 12 payments
  9. GARDASIL 9 $227 15 payments
  10. VAXELIS $186 12 payments
  11. Other $3,328 178 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

276 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record